Experienced private market investor and operating executive focused on growth-stage technology and healthcare companies. Scott Geppert brings deal sourcing, portfolio management and board experience across venture and growth equity investments, with emphasis on commercial strategy and scaling go-to-market operations. Prior roles span venture investing, corporate development and operator-level leadership; engages with founders on capital strategy and exit planning.
Experienced private market investor and operating executive focused on growth-stage technology and healthcare companies. Scott Geppert brings deal sourcing, portfolio management and board experience across venture and growth equity investments, with emphasis on commercial strategy and scaling go-to-market operations. Prior roles span venture investing, corporate development and operator-level leadership; engages with founders on capital strategy and exit planning.
Focuses on growth-stage technology and healthcare opportunities where operational involvement accelerates revenue scaling and commercial traction. Prefers concentrated, conviction investments paired with board or strategic advisory roles to drive go-to-market expansion and repeatable sales motions. Allocates capital toward companies with clear unit economics and defensible positioning, favoring multi-year growth horizons and milestone-driven follow-on reserves. Underwrites deals with quantifiable commercial KPIs, stress-tests exit paths via strategic acquirers or growth IPOs, and manages downside through staged financing and active portfolio governance.
Focuses on growth-stage technology and healthcare opportunities where operational involvement accelerates revenue scaling and commercial traction. Prefers concentrated, conviction investments paired with board or strategic advisory roles to drive go-to-market expansion and repeatable sales motions. Allocates capital toward companies with clear unit economics and defensible positioning, favoring multi-year growth horizons and milestone-driven follow-on reserves. Underwrites deals with quantifiable commercial KPIs, stress-tests exit paths via strategic acquirers or growth IPOs, and manages downside through staged financing and active portfolio governance.
| Trades 385 | Longs Won 268/385 69% | Profit Factor 38.39 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $348,347.22 |
| Average Win $131,767.91 | Best Trade (Dec 30) $3.78M | Sharpe Ratio 0.52 |
| Average Loss -$7,862.43 | Worst Trade (Jun 14) -$124,997.62 | Z-Score -3.91 (100%) |
| Commissions $0 | Avg. Trade Length 9m 5d | Expectancy $89,334.8 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 21,277 | 19,149 | 17,021 | 14,894 | 12,766 | 10,638 | 8,511 | 6,383 | 4,255 | 2,128 |